Close

Chardan Capital Markets Downgrades Audentes Therapeutics (BOLD) to Neutral Dec 4, 2019 08:05AM
Audentes Therapeutics to Participate in Upcoming Investor Conferences Oct 1, 2019 08:00AM
Audentes Therapeutics (BOLD) PT Raised to $50 at Chardan Capital Markets Sep 3, 2019 07:58AM
Pre-Open Stock Movers 02/25: (ONCE) (CMTA) (QURE) Higher; (MDR) (CRON) (NBR) Lower (more...) Feb 25, 2019 09:25AM
Chardan Capital Markets Upgrades Audentes Therapeutics (BOLD) to Buy Feb 24, 2019 09:23PM


Sep 26, 2018 08:00AM Audentes Therapeutics to Participate in Upcoming Investor Conferences
Jun 26, 2018 04:54AM Chardan Capital Markets Starts Audentes Therapeutics (BOLD) at Neutral
Sep 19, 2017 08:00AM Audentes Therapeutics to Present at Upcoming Investor Conferences